Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DEVICE

focused power ultrasound mediated inferior perirenal adipose tissue modification

"This novel focused power ultrasound is an externally delivered, completely noninvasive focused therapeutic ultrasound device. It is capable of focusing the resulting ultrasound beam to a small cigar-shaped volume and monitoring the temperature of the target area, which leads to the rapid elevation of the peri-renal adipose tissue temperature and the destruction of target tissue eventually."

DEVICE

sham-control group

Participants will receive the sham control therapy (including peri-renal fat ultrasonic measurement and localization, focused ultrasound treatment parameters setting), however, without initiating the focused ultrasound equipment.

Trial Locations (3)

210000

RECRUITING

The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing

210029

RECRUITING

JiangSu Province Hospital / The First Affiliated Hospital of Nanjing Medical University, Nanjing

215000

RECRUITING

Suzhou Municipal Hospital, Suzhou

All Listed Sponsors
collaborator

The Affiliated Jiangning Hospital of Nanjing Medical University

OTHER

collaborator

Suzhou Municipal Hospital

OTHER

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER